Pleuritis Complicating Pulmonary Infection of Mycobacterium kyorinense
Abstract
Mycobacterium kyorinense is a rare mycobacterium. A 58-year-old man presented with sputum production and left-sided chest pain. Thickened left pulmonary cyst and pleural effusion were observed. A culture of the pleural fluid was negative, but the adenosine deaminase level was elevated. The patient was clinically diagnosed with M. kyorinense infection because this mycobacterium was identified in sputum samples on two occasions. The effusion and chest pain improved following treatment with levofloxacin, clarithromycin, and streptomycin. Identification of M. kyorinense is clinically significant because of its drug resistance. To our knowledge, this is the first reported case of pleuritis caused by a pulmonary M. kyorinense infection.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.